Baillie Gifford & Co’s Cellectis CLLS Stock Holding History
Bought
Maintained
Sold
Other funds holding CLLS
LFCM
BGI
Baillie Gifford & Co's CLLS Position: Q2 2025 in Review
Baillie Gifford & Co sold out of Cellectis (CLLS) in Q2 2025, closing a stake of 139,047 shares — an estimated $172K sold.
Baillie Gifford & Co first reported a position in CLLS in Q2 2021 and held it in 16 quarters. The position peaked at $16M in Q2 2021. 24 funds tracked by Wall St. Rank hold CLLS as of Q2 2025.
- Baillie Gifford & Co reported no remaining Cellectis position as of Q2 2025 after selling out during the quarter.
- Baillie Gifford & Co sold 139,047 Cellectis shares in Q2 2025, an estimated $172K.
- Baillie Gifford & Co first reported a position in Cellectis in Q2 2021 and held it in 16 quarters.
- Baillie Gifford & Co's Cellectis position peaked at $16M in Q2 2021.
- 24 funds tracked by Wall St. Rank held Cellectis as of Q2 2025.
Based on Baillie Gifford & Co's 13F filing for Q2 2025, filed 6 Aug 2025.